KOSPI · Healthcare · ₩939B
₩66,800-1.76%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 23.8% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“신약 투자와 해외 확장이 다음 성장을 차근차근 준비해요.”
In the company's words · 2026 2분기 filing